NASDAQ: HBIO
Harvard Bioscience Inc Stock Ownership - Who owns Harvard Bioscience?

Insider buying vs selling

Have Harvard Bioscience Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Stephen J. DenelskyDirector2026-03-1710,000$4.87
$48.70kBuy
William SniderDirector2026-03-178,475$4.85
$41.10kBuy
John D. DukeChief Executive Officer2026-03-165,000$5.01
$25.05kBuy
Mark T. FrostChief Financial Officer2026-03-165,000$5.00
$25.00kBuy
William SniderDirector2026-03-1612,525$4.99
$62.50kBuy

1 of 1

HBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HBIO insiders and whales buy or sell their stock.

HBIO Shareholders

What type of owners hold Harvard Bioscience Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Skystone Advisors LLC316.02%14,452,038$125.44MInsider
James W. Green84.96%3,885,380$33.73MInsider
Chane Graziano65.71%3,005,150$26.08MInsider
Hso Limited Partnership60.29%2,757,257$23.93MInsider
David Green31.94%1,460,467$12.68MInsider
Bertrand Loy12.16%556,208$4.83MInsider
Earl R. Lewis10.43%477,050$4.14MInsider
Susan M. Luscinski10.27%469,720$4.08MInsider
Jeffrey Duchemin10.16%464,528$4.03MInsider
John F. 1. Kennedy7.07%323,344$2.81MInsider

1 of 3

HBIO vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HBIO0.01%99.99%Net Buying
POCI0.03%99.97%Net BuyingNet Buying
NEPH0.00%100.00%Net BuyingNet Buying
ZJYL0.00%67.79%
MLSS0.01%55.86%

Harvard Bioscience Stock Ownership FAQ

Who owns Harvard Bioscience?

Harvard Bioscience (NASDAQ: HBIO) is owned by 0.04% institutional shareholders, 668.31% Harvard Bioscience insiders, and 0.00% retail investors. Skystone Advisors LLC is the largest individual Harvard Bioscience shareholder, owning 14.45M shares representing 316.02% of the company. Skystone Advisors LLC's Harvard Bioscience shares are currently valued at $125.44M.

If you're new to stock investing, here's how to buy Harvard Bioscience stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.